Literature DB >> 479763

Detection of a mediator derived from endotoxin-stimulated macrohpages that induces the acute phase serum amyloid A response in mice.

J D Sipe, S N Vogel, J L Ryan, K P McAdam, D L Rosenstreich.   

Abstract

The mechanism by which LPS stimulates an acute phase serum amyloid A (SAA) response in C3H mice has been studied. A factor (SAA inducer) appears in the blood of C3H/HeN (lipopolysaccharide [LPS]-sensitive) mice approximately 1 h after administration of LPS, which, when passively administered, can induce C3H/HeJ mice to produce SAA although they are resistant to the LPS itself. SAA inducer has been detected in the culture medium of LPS treated C3H/HeN macrophages but not spleen cells. Thus, two stages in the induction of the acute phase SAA response are now recognized: a latent period of 2-3 h during which the SAA concentration remains at baseline values and in which SAA inducer appears, and the period of synthesis of SAA which lasts for approoximately 24 h past induction. It is proposed that a macrophage response to LPS is responsible for production of the serum mediator which induces SAA synthesis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 479763      PMCID: PMC2185651          DOI: 10.1084/jem.150.3.597

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  The effect of glucocorticoid antagonizing factor on hepatoma cells.

Authors:  K J Goodrum; L J Berry
Journal:  Proc Soc Exp Biol Med       Date:  1978-12

2.  Murine amyloidosis: immunologic characterization of amyloid fibril protein.

Authors:  C Isersky; D L Page; P Cuatrecasas; R A DeLellis; G G Glenner
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

3.  Immunochemical studies on the nature of the serum component (SAA) related to secondary amyloidosis.

Authors:  T F Ignaczak; J D Sipe; F P Linke; G G Glenner
Journal:  J Lab Clin Med       Date:  1977-05

4.  Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation.

Authors:  K P McAdam; R J Elin; J D Sipe; S M Wolff
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

5.  Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin.

Authors:  R P Linke; J D Sipe; P S Pollock; T F Ignaczak; G G Glenner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

6.  Variation with age and disease of an amyloid A protein-related serum component.

Authors:  C J Rosenthal; E C Franklin
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

7.  Amyloid-related serum protein SAA from three animal species: comparison with human SAA.

Authors:  R F Anders; J B Natvig; K Sletten; G Husby; K Nordstoga
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

8.  Localization of amyloid-related serum protein SAA-like material to intermediate (10 nm) filaments of cultured human embryonal fibroblasts.

Authors:  E Linder; V P Lehto; I Virtanen; S Stenman; J B Natvig
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

9.  Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes.

Authors:  G Lavie; D Zucker-Franklin; E C Franklin
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

10.  Control of the acute phase response. Demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit.

Authors:  I Kushner; G Feldmann
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

View more
  39 in total

1.  Interleukin-6 is necessary, but not sufficient, for induction of the humanC-reactive protein gene in vivo.

Authors:  B Weinhold; A Bader; V Poli; U Rüther
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

Review 2.  Interleukin-6 and the acute phase response.

Authors:  P C Heinrich; J V Castell; T Andus
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

3.  Alzheimer's disease brain-derived ubiquitin has amyloid-enhancing factor activity: behavior of ubiquitin during accelerated amyloidogenesis.

Authors:  K Alizadeh-Khiavi; J Normand; S Chronopoulos; Z Ali-Khan
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

4.  Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice.

Authors:  M Matsumoto; S Matsubara; T Matsuno; M Tamura; K Hattori; H Nomura; M Ono; T Yokota
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

Review 5.  Hepatic acute phase reaction in vivo and in vitro.

Authors:  H Baumann
Journal:  In Vitro Cell Dev Biol       Date:  1989-02

6.  Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis.

Authors:  J A Schmidt; C N Oliver; J L Lepe-Zuniga; I Green; I Gery
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

7.  The acute-phase response of cultured rat hepatocytes. System characterization and the effect of human cytokines.

Authors:  A Koj; J Gauldie; E Regoeczi; D N Sauder; G D Sweeney
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

8.  Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin.

Authors:  F Gonzalez-Crussi; W Hsueh
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

9.  Serum amyloid A (SAA) in viral infection: rubella, measles and subacute sclerosing panencephalitis (SSPE).

Authors:  R Shainkin-Kestenbaum; S Zimlichman; Y Winikoff; M Pras; C Chaimovitz; I Sarov
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

10.  Interleukin 1 mediated acceleration of type II collagen-induced arthritis: effects of anti-inflammatory or anti-arthritic drugs.

Authors:  J T Hom; V L Gliszczynski; H W Cole; A M Bendele
Journal:  Agents Actions       Date:  1991-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.